Lindsay Wilson Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 700 Childrens Dr, Columbus, OH 43205 Phone: 614-722-9376 Fax: 614-722-9069 |
Mr. Roosevelt Williams Jr. Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1791 Alum Creek Dr, Columbus, OH 43207 Phone: 614-445-8131 |
Mr. Mark Griff Ross, LCDC III 141287 Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 5460 Cleveland Ave, Columbus, OH 43231 Phone: 614-568-8236 Fax: 614-271-3175 |
Jill R Fetzer Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 524 W Broad St, Columbus, OH 43215 Phone: 614-662-1020 Fax: 614-662-1023 |
Krista Miller, LCDC II Counselor Medicare: Not Enrolled in Medicare Practice Location: 100 Noe Bixby Rd, Columbus, OH 43213 Phone: 614-892-2454 |
Stephanie M Linn, LPCC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 495 E Main St, Columbus, OH 43215 Phone: 614-355-7150 Fax: 614-355-7855 |
Beryl Akinyi Nyambok Clark Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 360 S Grant Ave, Columbus, OH 43215 Phone: 614-407-1243 |
Sheila Deshone Ingram, CDCA Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1791 Alum Creek Dr, Columbus, OH 43207 Phone: 614-445-8131 |
Bria Lee Nicole Ewing, LPCC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 92 Northwoods Blvd Ste C1, Columbus, OH 43235 Phone: 216-202-0903 |
Seth R Solis Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1791 Alum Creek Dr, Columbus, OH 43207 Phone: 614-445-8131 |
Dustin Flynn Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 40 W Long St, Columbus, OH 43215 Phone: 614-689-4477 |
Kelley Kramer-sieger Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 399 E Main St, Columbus, OH 43215 Phone: 614-355-8550 Fax: 614-355-8593 |
Kenneth Brooks Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 360 S Grant Ave, Columbus, OH 43215 Phone: 614-398-3470 |
Gabrielle H Plata-madrid, CT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1751 E Long St, Columbus, OH 43203 Phone: 614-253-8050 |
Mr. Augustine Chea Counselor Medicare: Not Enrolled in Medicare Practice Location: 3121 W Broad St, Columbus, OH 43204 Phone: 614-869-2002 Fax: 614-792-6240 |
Aaron David Hamilton Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 360 S Grant Ave, Columbus, OH 43215 Phone: 614-398-3470 |
Heath Austin Mccall Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 825 Dennison Ave, Columbus, OH 43215 Phone: 614-291-4691 Fax: 614-291-6323 |
Dr. Adrienne Erby, PHD Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 5969 E Livingston Ave Ste 100, Columbus, OH 43232 Phone: 614-864-2700 Fax: 614-864-2702 |
Barbara Brown Counselor Medicare: Not Enrolled in Medicare Practice Location: 16 W Long St, Columbus, OH 43215 Phone: 614-225-0990 Fax: 614-225-0988 |
Keaundrea Nicole Scott, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 495 E Main St, Columbus, OH 43215 Phone: 614-355-7150 Fax: 614-355-7855 |
News Archive
A team at The Scripps Research Institute has won a $1,784,000 grant from the California Institute for Regenerative Medicine (CIRM). The funding will support the development of a new method for detecting DNA damage in stem cells to ensure that only the highest quality cells are used in transplantation or therapy.
Exposure to C. difficile in infancy produces an immune response that might protect against this gastrointestinal infection later in childhood, according to a study published in Clinical Infectious Diseases journal
Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.
T cell receptors are among the most important molecules in the immune system because of their role in recognizing the antigens that signal such threats as viruses and cancer. The receptors must also distinguish these threats from the body's own cells to avoid triggering an unwanted immune system response.
› Verified 5 days ago